BIVRX vs. QAMNX
BIVRX (Invenomic Fund) and QAMNX (Federated Hermes MDT Market Neutral A) are both Long-Short funds. Over the past 3 years, BIVRX returned -6.23%/yr vs 10.88%/yr for QAMNX. At a 0.07 correlation, their price movements are largely independent. BIVRX charges 2.48%/yr vs 1.86%/yr for QAMNX.
Performance
BIVRX vs. QAMNX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BIVRX achieves a -18.27% return, which is significantly lower than QAMNX's -0.85% return.
BIVRX
- 1D
- 4.96%
- 1M
- -6.65%
- YTD
- -18.27%
- 6M
- -16.19%
- 1Y
- -11.83%
- 3Y*
- -6.23%
- 5Y*
- 6.88%
- 10Y*
- —
QAMNX
- 1D
- 0.33%
- 1M
- -0.19%
- YTD
- -0.85%
- 6M
- -1.05%
- 1Y
- 2.99%
- 3Y*
- 10.88%
- 5Y*
- —
- 10Y*
- —
BIVRX vs. QAMNX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
BIVRX Invenomic Fund | -18.27% | 4.39% | -9.03% | 16.47% | 49.61% | 6.94% |
QAMNX Federated Hermes MDT Market Neutral A | -0.85% | 10.00% | 17.33% | 4.71% | 9.19% | 12.29% |
Correlation
The correlation between BIVRX and QAMNX is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.18 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.04 |
Correlation (All Time) Calculated using the full available price history since Sep 22, 2021 | 0.07 |
The correlation between BIVRX and QAMNX shifts across timeframes, from -0.04 (3 years) to 0.18 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BIVRX vs. QAMNX — Risk / Return Rank
BIVRX
QAMNX
BIVRX vs. QAMNX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invenomic Fund (BIVRX) and Federated Hermes MDT Market Neutral A (QAMNX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BIVRX | QAMNX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.89 | ||
| Sortino ratioReturn per unit of downside risk | -1.21 | ||
| Omega ratioGain probability vs. loss probability | 0.94 | 1.09 | -0.15 |
| Calmar ratioReturn relative to maximum drawdown | -0.44 | 0.72 | -1.16 |
| Martin ratioReturn relative to average drawdown | -1.30 | 1.61 | -2.91 |
Loading charts...
Drawdowns
BIVRX vs. QAMNX - Drawdown Comparison
The maximum BIVRX drawdown since its inception was -27.37%, which is greater than QAMNX's maximum drawdown of -17.97%. Use the drawdown chart below to compare losses from any high point for BIVRX and QAMNX.
Loading charts...
Drawdown Indicators
| BIVRX | QAMNX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -27.37% | -17.97% | -9.40% |
Max Drawdown (1Y)Largest decline over 1 year | -26.97% | -4.16% | -22.81% |
Max Drawdown (3Y)Largest decline over 3 years | -27.37% | -4.16% | -23.21% |
Max Drawdown (5Y)Largest decline over 5 years | -27.37% | — | — |
Current DrawdownCurrent decline from peak | -23.77% | -2.85% | -20.92% |
Average DrawdownAverage peak-to-trough decline | -6.14% | -5.12% | -1.02% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.15% | 1.87% | +7.28% |
Volatility
BIVRX vs. QAMNX - Volatility Comparison
Invenomic Fund (BIVRX) has a higher volatility of 13.48% compared to Federated Hermes MDT Market Neutral A (QAMNX) at 2.29%. This indicates that BIVRX's price experiences larger fluctuations and is considered to be riskier than QAMNX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BIVRX | QAMNX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.48% | 2.29% | +11.19% |
Volatility (6M)Calculated over the trailing 6-month period | 22.65% | 5.26% | +17.39% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.73% | 6.72% | +20.01% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.15% | 13.80% | +4.35% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.93% | 13.80% | +4.13% |
BIVRX vs. QAMNX - Expense Ratio Comparison
BIVRX has a 2.48% expense ratio, which is higher than QAMNX's 1.86% expense ratio.
Dividends
BIVRX vs. QAMNX - Dividend Comparison
BIVRX's dividend yield for the trailing twelve months is around 2.36%, more than QAMNX's 1.54% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
BIVRX Invenomic Fund | 2.36% | 1.93% | 3.55% | 20.26% | 28.43% | 3.00% | 3.11% | 3.21% | 4.82% | 1.21% |
QAMNX Federated Hermes MDT Market Neutral A | 1.54% | 1.53% | 1.85% | 5.89% | 11.74% | 20.80% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
BIVRX and QAMNX have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BIVRX has higher volatility (13.48%) compared to QAMNX (2.29%). In terms of maximum drawdown, BIVRX dropped -27.37% vs QAMNX's -17.97%.
QAMNX currently has the higher Sharpe Ratio (0.45 vs -0.45), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BIVRX and QAMNX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer